KANAGAWA, Japan--(BUSINESS WIRE)--Lilium Otsuka Co., Ltd., an affiliated company of Otsuka Holdings Co., Ltd., (TOKYO:4578) announced that the National Institute of Advanced Industrial Science and Technology (AIST), UriCare Inc., and Lilium Otsuka signed a contract for research and development and marketing of products using ultrasound urinary volume sensor technology owned by UriCare and AIST.
UriCare has been marketing the unique urinary volume sensor, Yuririn USH-052 (medical device approval number: 21600BZZ00466000) in Japan which is a portable post-void residual measuring and urine volume monitor that allows continuous measurement through the attachment of a flat-type probe to the area of the abdomen corresponding to the bladder, and estimates the volume of urine collected in the bladder with a unique indicator that uses ultrasound. Lilium Otsuka will proceed with development of next-generation versions based on this technology.
“The beauty of this technology is that it can continuously measure urine volume in the bladder. It will contribute efficient control of the appropriate timing of urination, such as through clean intermittent catheterization in patients who have lost the ability to urinate for any reason and through urinary induction by nurse or caregiver during rehabilitation.” commented Isao Shirasaki, President and Representative Director of Lilium Otsuka.
Under the corporate philosophy of “Otsuka-People creating new products for better health worldwide” shared by the Otsuka Group, Lilium Otsuka will contribute to the health of people worldwide by creating new markets.
Lilium Otsuka Co., Ltd. http://www.lilium.otsuka
UriCare Inc. http://www.yuririn.jp/
